Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow CAH
Cardinal Health, Inc. (CAH) Return on equity
Cardinal Health, Inc.'s return on equity over the twelve months to 30 June 2026 was −64.0%. Over the past ten years it has ranged from −172.4% (fiscal 2022) to 34.1% (fiscal 2021); the current reading is higher than 25% of that period. That is below the Medical Distribution industry median of 0.00% and below the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | −64.0% | (10.58) |
| FY2025 | −53.4% | (25.78) |
| FY2024 | −27.6% | (9.60) |
| FY2023 | −18.0% | 154.41 |
| FY2022 | −172.4% | (206.51) |
| FY2021 | 34.1% | 125.09 |
| FY2020 | −91.0% | (113.01) |
| FY2019 | 22.0% | 18.03 |
| FY2018 | 3.97% | (15.26) |
| FY2017 | 19.2% | (3.02) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| COR Cencora, Inc. compare | 96.3% |
| ACH Accendra Health, Inc. compare | 72.6% |
| HSIC Henry Schein, Inc. compare | 10.2% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| HKPD Cellyan Biotechnology Co., Ltd compare | 0.00% |
| CAH Cardinal Health, Inc. | −64.0% |
| COSM Cosmos Health Inc. compare | −104.0% |
| FOCL FocalTherics compare | −133.5% |
| MCK McKesson Corporation compare | −168.5% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CAH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement